ABK Biomedical

ABK Biomedical Inc. is pursuing development, production and sale of embolic agents and peripheral vascular delivery devices.  ABK innovates integrated devices to simplify clinical procedures performed by interventional radiologists, with the lead system OccluRad /OccluDel, targeting hypervascular tumors including uterine fibroids. ABK BioMedical has developed OccluRad beads and  the OccluDel device providing a  simpler,  safer  and  more  cost  effective  solution  to treating hypervascular tumors.